Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1916-1931
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1916
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1916
Figure 4 Corilagin attenuates inflammatory infiltration in the kidneys of diabetic nephropathy mice.
A: Representative images of immunohistochemical staining for IL-1β in kidney tissue of mice (magnification 200 ×); B-D: The levels of inflammatory factors (IL-1β, TNF-α, and IL-6) measured by ELISA in kidney tissue; E-G: Real-time quantitative PCR was carried out to determine the mRNA expression of IL-1β, TNF-α, and IL-6 in kidney tissue of mice. Data are presented as the mean ± SD (n = 8 in each group). aP < 0.001 vs control group; bP < 0.001 vs DN group. Cor: Corilagin; DN: Diabetic nephropathy.
- Citation: Lou Y, Luan YT, Rong WQ, Gai Y. Corilagin alleviates podocyte injury in diabetic nephropathy by regulating autophagy via the SIRT1-AMPK pathway. World J Diabetes 2024; 15(9): 1916-1931
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1916.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1916